RIGL: Rega marang dodolan Rigel Pharmaceuticals Inc
Stable revenue from hematology products funds oncology R&D and distribution for Rigel Pharmaceuticals (RIGL). The price-to-sales ratio reflects current dynamics, where 3.00 shows the actual value of the metric. The team is focused on the commercial launch of drugs and a premium benefits package. The recruitment of blood and immunity experts is based on the support of scientific research and competitive compensation.
Rincian analitis perusahaan Rigel Pharmaceuticals Inc (RIGL)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Rasio Utang marang Modal Rigel Pharmaceuticals|RIGL - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Rigel Corp|RIGL - Utang perusahaan|Rasio utang marang kapitalisasi buku Rigel Pharmaceuticals Inc|RIGL - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Rigel Pharmaceuticals|Rasio likuiditas kritis rigel.com
- informasi bathi lan kelipatan valuasi:
RIGL - Bathi resik|Penghasilan resik sing dikarepake Rigel Pharmaceuticals|RIGL - Pangali P/E|Pangali Forward P/E Rigel Pharma|RIGL - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Rigel Pharmaceuticals Inc|RIGL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Rigel Pharmaceuticals|RIGL - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan rigel.com|RIGL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Rigel Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:rigel.com RIGL
The P/S ratio compares market capitalization to sales volume, providing a real-time assessment of shifting investor sentiment regarding the value of each unit of revenue. This price-to-sales metric allows for an evaluation of whether the business is overvalued or undervalued, which is critically important for Rigel Pharmaceuticals (RIGL) during the commercial scaling of its oncology portfolio and its transition toward operational profitability.
Karo sapa Rigel Pharmaceuticals saingan
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PTGX (Protagonist Corp)|IMVT: Multiplikator P/S|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols) - Multiplikator P/S|ADPT - Multiplikator rega marang pendapatan|Multiplikator P/S CLDX|AUPH - Rega marang dodolan|Rasio rega marang pendapatan BioCryst BCRX|veratx.com - Rasio rega marang pendapatan|DNTH: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PHVS (Pharvaris NV)|AbCellera Biologics Inc (ABCL) - Rasio rega marang pendapatan|Rasio rega marang dodolan TRML (Tourmaline)|PGEN (Precigen, Inc.) - Multiplikator P/S|PHAR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NKTR|Multiplikator P/S Upstream Bio, Inc. (UPB)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Rasio kapitalisasi pasar marang pendapatan IMNM|GOSS - Rasio rega marang pendapatan|kalvista.com (KALV) - Kapitalisasi marang pendapatan|SEPN: Multiplikator P/S|Pieris Pharma (PVLA) - Multiplikator P/S|SVRA (Savara Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan AnaptysBio Inc. (ANAB)|Multiplikator P/S ATXS|ENGN - Rega marang dodolan|RAPT Therapeutics - Kapitalisasi marang pendapatan|Multiplikator P/S Aerovate Therapeutics, Inc. JBIO|ACRS: Kapitalisasi marang pendapatan|Kyverna Therapeutics, Inc - Kapitalisasi marang volume dodolan|TLSA: Multiplikator P/S|CABA - Koefisien rega marang pendapatan|VTYX (Ventyx Biosciences, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Theratechnologies, Inc. (THTX)|Multiplikator P/S AVTX|Multiplikator P/S Eledon Pharmaceuticals, Inc (ELDN)|Rasio rega marang pendapatan Agenus AGEN|climbbio.com - Rasio rega marang pendapatan|ZURA - Rasio rega marang pendapatan|Koefisien rega marang pendapatan aTyr Pharma Inc ATYR|adagene.com (ADAG) - Rasio rega marang pendapatan|Ikena Oncology - Rasio kapitalisasi pasar marang pendapatan|STTK (Shattuck Labs Inc) - Multiplikator P/S|Equillium Bio (EQ) - Koefisien rega marang pendapatan|Multiplikator P/S CNTB|immunic-therapeutics.com (IMUX) - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Atara Bio ATRA|InflaRx NV - Rasio rega marang pendapatan|XFOR - Rasio rega marang pendapatan|Rasio rega marang dodolan ACET|CELU: Multiplikator P/S|INmune Bio Inc - Rasio kapitalisasi pasar marang pendapatan|BRNS (Barinthus Bio) - Multiplikator P/S|Multiplikator P/S Kezar Life Sciences Inc|Rasio rega marang pendapatan SAB Biotherapeutics (SABS)|AKTX (akaritx.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Enlivex Therapeutics Ltd. ENLV|QTTB - Kapitalisasi marang pendapatan|GeoVax Labs Inc - Multiplikator P/S|EDSA - Multiplikator P/S|IBIO (iBio, Inc.) - Kapitalisasi marang pendapatan|Carisma Therapeutics Inc. - Rasio kapitalisasi pasar marang pendapatan|XTLB (XTL Biopharmaceuticals Ltd.) - Multiplikator P/S|Bolt Bio (BOLT) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan HCW Biologics Inc. (HCWB)|Kapitalisasi marang pendapatan aptevotherapeutics.com APVO|Rasio rega marang pendapatan AIM ImmunoTech Inc. AIM|ADTX - Kapitalisasi marang pendapatan|GRI: Kapitalisasi marang pendapatan|XRTX - Multiplikator P/S|ReShape Lifesciences (HIND) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan REVB|INDP (Indaptus Therapeutics) - Multiplikator P/S|Rega marang dodolan scinai.com SCNI|Rasio rega marang pendapatan CalciMedica, Inc. (CALI)|AFMD (affimed.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos)|Koefisien rega marang pendapatan HOOKIPA Pharma, Inc. (HOOK)|IGM Bio - Multiplikator P/S|Multiplikator rega marang pendapatan iteostherapeutics.com (ITOS)|OCEA: Multiplikator P/S|Rega marang dodolan TC BioPharm (Holdings) Plc (TCBP)|Rasio rega marang pendapatan Third Harmonic Bio, Inc
